Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone.
作者信息
Le Turnier Paul, Tattevin Pierre, Varon Emmanuelle, Duval Xavier
机构信息
Infectious Diseases Department, Centre Hospitalier de Cayenne, Cayenne, French Guiana.
Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
出版信息
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0001223. doi: 10.1128/aac.00012-23. Epub 2023 Mar 7.
Abstract
摘要
相似文献
1
Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone.急性细菌性脑膜炎的经验性治疗：呼吁使用高剂量头孢噻肟或头孢曲松
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0001223. doi: 10.1128/aac.00012-23. Epub 2023 Mar 7.
2
Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis.万古霉素应作为疑似细菌性脑膜炎经验性治疗的一部分。
J Pediatric Infect Dis Soc. 2019 May 11;8(2):187-188. doi: 10.1093/jpids/piy121.
3
Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.头孢噻肟或头孢曲松敏感及非敏感肺炎链球菌性脑膜炎患儿的细菌学转归
Pediatr Infect Dis J. 2000 Oct;19(10):1015-7. doi: 10.1097/00006454-200010000-00018.
4
Reply to Le Turnier et al., "Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone".对勒蒂尔尼耶等人《急性细菌性脑膜炎的经验性治疗：呼吁使用高剂量头孢噻肟或头孢曲松》一文的回复
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0005023. doi: 10.1128/aac.00050-23. Epub 2023 Mar 7.
5
Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.大剂量头孢噻肟和万古霉素治疗细菌性脑膜炎患儿脑脊液中对头孢菌素中度耐药肺炎链球菌的杀菌活性。
Antimicrob Agents Chemother. 1997 Sep;41(9):2050-2. doi: 10.1128/AAC.41.9.2050.
6
Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.对于对广谱头孢菌素中度敏感的肺炎链球菌所致脑膜炎，抗生素治疗及急性转归情况。
Antimicrob Agents Chemother. 1994 May;38(5):918-23. doi: 10.1128/AAC.38.5.918.
7
Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.儿童细菌性脑膜炎治疗期间头孢噻肟和头孢曲松的脑脊液水平
Int J Antimicrob Agents. 2005 Nov;26(5):408-11. doi: 10.1016/j.ijantimicag.2005.08.005. Epub 2005 Oct 7.
8
[Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Enferm Infecc Microbiol Clin. 1997 May;15(5):276-7.
9
Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.青霉素和头孢菌素耐药性肺炎球菌性脑膜炎：真实世界和指南中的治疗。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0082022. doi: 10.1128/aac.00820-22. Epub 2022 Nov 3.
10
Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.头孢曲松与地塞米松联合治疗实验性耐头孢菌素肺炎球菌脑膜炎的评估
J Antimicrob Chemother. 2000 Mar;45(3):315-20. doi: 10.1093/jac/45.3.315.
引用本文的文献
1
Reply to Le Turnier et al., "Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone".对勒蒂尔尼耶等人《急性细菌性脑膜炎的经验性治疗：呼吁使用高剂量头孢噻肟或头孢曲松》一文的回复
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0005023. doi: 10.1128/aac.00050-23. Epub 2023 Mar 7.
本文引用的文献
1
Invasive pneumococcal infections in France: Changes from 2009 to 2021 in antibiotic resistance and serotype distribution of Streptococcus pneumoniae based on data from the French Regional Pneumococcal Observatories network.法国侵袭性肺炎球菌感染：基于法国区域肺炎球菌观察网络的数据，2009 年至 2021 年肺炎链球菌对抗生素耐药性和血清型分布的变化。
Infect Dis Now. 2023 Feb;53(1):104632. doi: 10.1016/j.idnow.2022.11.001. Epub 2022 Nov 12.
2
Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.青霉素和头孢菌素耐药性肺炎球菌性脑膜炎：真实世界和指南中的治疗。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0082022. doi: 10.1128/aac.00820-22. Epub 2022 Nov 3.
3
CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective study.成人肺炎球菌性脑膜炎患者脑脊液中头孢噻肟浓度：一项多中心回顾性研究。
J Antimicrob Chemother. 2021 Aug 12;76(9):2352-2355. doi: 10.1093/jac/dkab191.
4
Continuous versus intermittent infusion of cefotaxime in critically ill patients: a randomized controlled trial comparing plasma concentrations.危重症患者头孢噻肟持续与间断输注：比较血浆浓度的随机对照试验
J Antimicrob Chemother. 2020 Feb 1;75(2):441-448. doi: 10.1093/jac/dkz463.
5
Management of acute community-acquired bacterial meningitis (excluding newborns). Long version with arguments.急性社区获得性细菌性脑膜炎（不包括新生儿）的管理。带论据的长篇版本。
Med Mal Infect. 2019 Sep;49(6):405-441. doi: 10.1016/j.medmal.2019.03.009. Epub 2019 Aug 8.
6
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram.大剂量头孢曲松治疗细菌性脑膜炎及基于列线图优化给药方案
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00634-19. Print 2019 Sep.
7
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study.高剂量头孢曲松治疗中枢神经系统感染的耐受性：一项前瞻性多中心队列研究。
J Antimicrob Chemother. 2019 Apr 1;74(4):1078-1085. doi: 10.1093/jac/dky553.
8
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.欧洲临床微生物学与感染病学会指南：急性细菌性脑膜炎的诊断与治疗
Clin Microbiol Infect. 2016 May;22 Suppl 3:S37-62. doi: 10.1016/j.cmi.2016.01.007. Epub 2016 Apr 7.
Zotero 插件